A.R.T. Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-17,291
| Closed | -$1.17M | – | 1345 |
|
2019
Q3 | $1.17M | Buy |
17,291
+9,800
| +131% | +$660K | 0.06% | 488 |
|
2019
Q2 | $642K | Sell |
7,491
-10,700
| -59% | -$917K | 0.04% | 640 |
|
2019
Q1 | $1.62M | Buy |
18,191
+11,164
| +159% | +$992K | 0.1% | 316 |
|
2018
Q4 | $598K | Buy |
+7,027
| New | +$598K | 0.04% | 640 |
|
2018
Q2 | – | Sell |
-33,127
| Closed | -$2.69M | – | 1431 |
|
2018
Q1 | $2.69M | Sell |
33,127
-1,100
| -3% | -$89.2K | 0.11% | 273 |
|
2017
Q4 | $3.05M | Buy |
34,227
+21,700
| +173% | +$1.93M | 0.14% | 218 |
|
2017
Q3 | $1.17M | Sell |
12,527
-40,473
| -76% | -$3.76M | 0.06% | 469 |
|
2017
Q2 | $4.81M | Buy |
53,000
+19,400
| +58% | +$1.76M | 0.26% | 70 |
|
2017
Q1 | $2.95M | Buy |
33,600
+10,600
| +46% | +$930K | 0.14% | 201 |
|
2016
Q4 | $1.91M | Buy |
+23,000
| New | +$1.91M | 0.11% | 280 |
|
2016
Q2 | – | Sell |
-8,670
| Closed | -$715K | – | 1368 |
|
2016
Q1 | $715K | Sell |
8,670
-23,200
| -73% | -$1.91M | 0.03% | 719 |
|
2015
Q4 | $3.34M | Sell |
31,870
-32,496
| -50% | -$3.4M | 0.16% | 158 |
|
2015
Q3 | $6.78M | Buy |
64,366
+55,264
| +607% | +$5.82M | 0.25% | 90 |
|
2015
Q2 | $1.24M | Buy |
+9,102
| New | +$1.24M | 0.04% | 640 |
|
2015
Q1 | – | Sell |
-63,952
| Closed | -$5.78M | – | 1435 |
|
2014
Q4 | $5.78M | Buy |
+63,952
| New | +$5.78M | 0.22% | 102 |
|
2014
Q3 | – | Sell |
-109,287
| Closed | -$6.8M | – | 1315 |
|
2014
Q2 | $6.8M | Buy |
109,287
+102,879
| +1,605% | +$6.4M | 0.35% | 45 |
|
2014
Q1 | $437K | Sell |
6,408
-102,483
| -94% | -$6.99M | 0.02% | 810 |
|
2013
Q4 | $7.66M | Buy |
108,891
+50,800
| +87% | +$3.57M | 0.41% | 32 |
|
2013
Q3 | $4.19M | Sell |
58,091
-17,556
| -23% | -$1.27M | 0.23% | 104 |
|
2013
Q2 | $4.22M | Buy |
+75,647
| New | +$4.22M | 0.14% | 207 |
|